{
  "docId": "019de076-9434-73df-8e70-401e13bb3d65",
  "docSlug": "692690be0ea25b83b6a4c7490ff14999",
  "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
  "authorId": "bioatla",
  "authorName": "BioAtla",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 50,
  "pageCount": 55,
  "prevPage": 49,
  "nextPage": 51,
  "slideType": "appendix_data",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 6,
  "notes": "The table tracks specific dosing schedules (Q2W, 3Q4W, 2Q3W) and their progression status.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/50",
  "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
  "deckJsonHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65.json",
  "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-50",
  "components": [
    {
      "bbox": {
        "h": 0.04,
        "w": 0.3,
        "x": 0.12,
        "y": 0.93
      },
      "kind": "source-note",
      "text": "*Currently no plans to internally explore NSCLC further at this time. NSCLC = non small cell lung cancer",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fc263000-128f-49fb-b570-48d53ab243e2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.86,
        "x": 0.07,
        "y": 0.229
      },
      "kind": "table",
      "text": "Indication, Dose, Maximum Patient #, Status. NSCLC, Q2W monotherapy, N ~ 20, Checkmark. NSCLC, Q2W in combo w/ nivolumab, N ~ 20, Checkmark. NSCLC, 3Q4W monotherapy, N ~ 20, Not advancing. Melanoma, Q2W monotherapy, N ~ 25, Fully enrolled.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4267258f-6b84-40ef-a18a-a4bc47d11615",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "Phase 2 CAB-ROR2 (BA3021) Summary of Dosing Regimens for Clinical Studies",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "696a27a7-e431-4b41-86be-5c9c5789e50a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}